Funded Startups in Oceania
Telix Pharmaceuticals’ $600M (2026-04-14) stands out as the only disclosed round in the $500M+ range; every other disclosed amount in the top set is $315M…
Telix Pharmaceuticals’ $600M (2026-04-14) stands out as the only disclosed round in the $500M+ range; every other disclosed amount in the top set is $315M or lower (e.g., AdvanCell $315M on 2026-07-15 and MoneyMe $264M on 2026-05-14), making it a clear outlier by size. The disclosed rounds are also time-bunched: the list spans 2026-03-30 to 2026-07-29, with multiple large checks clustering in April–June (e.g., Drift Protocol $100M on 2026-04-16; 4DMEDICAL $57M on 2026-03-30; Mesoblast $50M on 2026-06-24). Geographic concentration is visible as well, with Sydney appearing 13 times, Melbourne 8, and Perth 7. Sector-wise, biotechnology recurs across the roster (e.g., AdvanCell 2026-07-15 for $315M, Mesoblast 2026-06-24 for $50M, Telix Pharmaceuticals 2026-04-14 for $600M). Stage reporting is also skewed: 19 of the 46 disclosed rows carry “Series Unknown,” while “Seed” and “Pre-Seed” also appear repeatedly (e.g., Octopusbot Seed $690K on 2026-07-29; Outlier Space Pre-Seed $11M on 2026-07-29).
Most recent rounds
50 of 1,044994 more funded startups
This page shows the 50 most recent rounds (back to Mar 2026). The full 1,044-company history for this listing is available on a paid plan.
Unlock all 1,044 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the outlier by size, and how does it position against the rest of Oceania?
Telix Pharmaceuticals’ $600M (2026-04-14) dwarfs the next-largest disclosed amount of $315M (AdvanCell, 2026-07-15), and it is the only entry above $500M; the next tier tops out at $315M, $264M, and $104M (MoneyMe on 2026-05-14 and Tamboran Resources on 2026-04-07).
Do these funded rounds cluster in time, or are they evenly spread across the window?
They cluster toward mid-interval dates: major disclosed rounds land in April–June, including 4DMEDICAL $57M (2026-03-30), Drift Protocol $100M (2026-04-16), MoneyMe $264M (2026-05-14), and Mesoblast $50M (2026-06-24). The overall date range runs from 2026-03-30 to 2026-07-29, with the most recent entries on 2026-07-29 (e.g., Navi Medical Technologies $5M and Octopusbot $690K).
Are any cities over-represented among these recent funded startups?
Sydney is the dominant hub by count, appearing 13 times versus Melbourne (8) and Perth (7). Examples include multiple Sydney closings across stages and sizes such as MoneyMe $264M (2026-05-14), ESGagent.ai $310K (2026-07-13), and LendUs $5M (2026-07-08).
What does the stage mix look like when amounts are disclosed?
“Series Unknown” is the single most common disclosed label: 19 of 46 disclosed rows. Concrete anchors include AdvanCell $315M (2026-07-15) as Series D, while smaller early-stage examples include Outlier Space Pre-Seed $11M (2026-07-29) and Octopusbot Seed $690K (2026-07-29).
Which sectors show repeated presence in this Oceania set?
Biotechnology appears frequently across disclosed rounds and includes AdvanCell $315M (2026-07-15), Mesoblast $50M (2026-06-24), and Telix Pharmaceuticals $600M (2026-04-14). Energy is also recurrent (e.g., Comet Ridge $45M on 2026-06-24 and Tamboran Resources $104M on 2026-04-07), indicating multiple investment themes beyond a single vertical.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.